Boxer Capital’s Surrozen SRZN Stock Holding History

Boxer Capital’s Portfolio SRZN Stock Details SRZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,333	Closed	-$1.29M	–	76
2021 Q4	$1.29M	Hold	13,333	–	–	0.05%	70
2021 Q3	$1.42M	Buy	+13,333	New	+$1.88M	0.05%	85

Other funds holding SRZN

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Boxer Capital's SRZN Position: Q1 2022 in Review

Boxer Capital sold out of Surrozen (SRZN) in Q1 2022, closing a stake of 13,333 shares — an estimated $1.29M sold.

Boxer Capital first reported a position in SRZN in Q3 2021 and held it in 2 quarters. The position peaked at $1.42M in Q3 2021. 30 funds tracked by Wall St. Rank hold SRZN as of Q1 2022.

Boxer Capital reported no remaining Surrozen position as of Q1 2022 after selling out during the quarter.
Boxer Capital sold 13,333 Surrozen shares in Q1 2022, an estimated $1.29M.
Boxer Capital first reported a position in Surrozen in Q3 2021 and held it in 2 quarters.
Boxer Capital's Surrozen position peaked at $1.42M in Q3 2021.
30 funds tracked by Wall St. Rank held Surrozen as of Q1 2022.

Based on Boxer Capital's 13F filing for Q1 2022, filed 16 May 2022.